Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Bacil Pharma Financial Results

Bacil Pharma Limited reported audited financial results for the year ended March 2026. The board approved results showing a profit of ₹155.55 Lakhs from ordinary activities.

Source

BSE filing, NSE: BACPHAR. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Bacil Pharma Ltd: key numbers

Share price
₹19.36
Market cap
₹27.79 Cr
Revenue (annual)
₹0.00 Cr
Net profit (annual)
₹1.56 Cr
P/E (TTM)
44.0×Sector 46.1×
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Bacil Pharma Ltd

All →

Other financial results announcements

All →